[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100554043":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":30,"locations":40,"responsibleParty":55,"collaborators":25,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":25,"enrollmentInfo":66,"targetDuration":25,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":78,"whyStopped":25,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"University Hospital, Bordeaux","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"experimental arm","EXPERIMENTAL","Patients with type 2 diabetes included in the adapted physical activity arm for 12 months",[13],"Other: Adapted physical activity for 12 months",{"label":15,"type":16,"description":17,"interventionNames":18},"control arm","ACTIVE_COMPARATOR","Type 2 diabetes patients with standard prescription for adapted physical activity (6 months)",[19],"Other: Adapted physical activity for 6 months",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"Adapted physical activity for 12 months","6 additional months of adapted physical activity after the 6 first months",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Adapted physical activity for 6 months","standard 6-month prescription for adapted physical activity",[15],[31,35],{"name":32,"role":33,"phone":25,"phoneExt":25,"email":34},"CUGERONE Arnaud, Dr","CONTACT","arnaud.cugerone@u-bordeaux.fr",{"name":36,"role":33,"phone":37,"phoneExt":38,"email":39},"Fabienne SAUVETRE","05 57 82 14 87","+33","fabienne.sauvetre@chu-bordeaux.fr",[41],{"facility":42,"status":25,"city":43,"state":25,"zip":25,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Cabinet Médical Bergerac","Bergerac","France","FR",{"type":47,"coordinates":48},"Point",[49,50],0.48171,44.85157,{"lat":50,"lon":49},[53],{"name":54,"role":33,"phone":25,"phoneExt":25,"email":34},"Arnaud CUGERONE, Dr",{"type":56,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100554043","evaluation-of-the-effectiveness-of-extending-the-passerelle-system-for-prescribing-adapted-physical-activity-to-patients-with-type-2-diabetes-in-nouvelle-aquitaine-france-100554043",false,"NCT06493955","Evaluation of the Effectiveness of Extending the \"Passerelle\" System for Prescribing Adapted Physical Activity to Patients With Type 2 Diabetes in Nouvelle-AQUItaine (France)","PAPA-NAQUI","Inclusion Criteria:\n\n* Patients with type 2 diabetes with initial diagnosis of fasting blood glucose \\> 1.26 g\u002Fl on 2 occasions\n* Patient aged 18 or over\n* Patient with a Marshall score ≤ 3\n* Patient residing in the Nouvelle-Aquitaine region\n* Patient eligible for the \"Passerelle\" program\n* Patient willing to participate\n* Patient agreeing to take part in the study and having signed an informed consent form\n* Person affiliated or benefiting from a social security scheme.\n\nExclusion Criteria:\n\n* Patient with any other unstabilized pathology:\n* Cardiovascular: unstable angina, stress angina, malignant hypertension, recent myocardial infarction, unstabilized heart disease\n* Pulmonary: uncontrolled asthma, COPD exacerbation\n* Endocrine: diabetes with HbA1c \\> 9%, plantar perforator disease\n* Pregnant patient\n* Diabetic patient with contraindication to APA prescription\n* Patient under court protection","ALL","18 Years",{"count":67,"type":68},308,"ESTIMATED","INTERVENTIONAL",[71],"NA","Type 2 diabetes is on the increase worldwide. Two major risk factors have been identified: overweight and physical inactivity. National and international recommendations encourage general practitioner to guide patients in changing their lifestyle. As regards physical activity in France, general practitioner have been able to prescribe adapted physical activity (APA) for their patients since 2016. In type 2 diabetes, it is known that physical activity interventions are cost-effective. However, these interventions are often too expensive and far removed from real life. It is also known that the benefits of intervention increase up to 18 months, then diminish to zero at 36 months. In Nouvelle-Aquitaine, France, the \"PEPS Sport-santé network\", offers physical activity coaching for patients who are not sufficiently active: the \"Passerelle\" program. Patients can benefit from a weekly physical activity session for 6 months.\n\nThe investigators would therefore like to assess whether extending the existing \"Passerelle program\" by 6 months, with one session every 15 days, is effective in maintaining the volume of physical activity 12 months after the end of the intervention.",[74],"Diabetes Mellitus, Type 2",[74,76,77],"Adapted Physical Activity","general practice","NOT_YET_RECRUITING","2026-08-04",{"date":81,"type":82},"2026-08-07","ACTUAL",{"date":84,"type":68},"2026-09",{"date":86,"type":68},"2029-09",{"name":5,"class":6},1]